Zobrazeno 1 - 6
of 6
pro vyhledávání: '"C. L. Iñíguez"'
Autor:
J. T. Sánchez-Costa, R. B. Melero González, E. Fernández-Fernández, M. T. Silva, J. M. Belzunegui Otano, C. Moriano, J. Sanchez-Martin, J. Lluch Pons, I. Calvo, V. Aldasoro, L. Abasolo, J. Loricera, A. Ruiz Román, S. Castañeda, P. Moya, M. J. Garcia Villanueva, V. A. Navarro Angeles, C. Galisteo, A. Riveros, J. A. Román Ivorra, S. Labrada, M. Vasques Rocha, C. L. Iñíguez, M. Garcia Gonzalez, C. Molina, M. Alcalde Villar, A. J. Mas, E. De Miguel, J. Narváez, M. A. González-Gay, N. P. Garrido Puñal, P. Estrada, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:685-686
BackgroundEpidemiological information on Giant Cell Arteritis (GCA) comes mainly from the Scandinavian countries of northern Europe, which show a higher incidence than the countries of southern Europe. GCA clinical manifestations can be divided into
Autor:
G. Gonzalez Arribas, C. L. Iñíguez, F. Maceiras-Pan, V. Quevedo Vila, L. Fernández-Dominguez, J. A. Mosquera Martínez, C. García-Porrúa, J. L. Guerra-Vazquez, J. A. Pinto Tasende
Publikováno v:
Annals of the Rheumatic Diseases. 81:878.2-879
BackgroundPsoriatic arthritis (PsA) is a chronic inflammatory disease of highly variable presentation, which determines a physical and psychological deterioration, with a negative impact on the quality of life of patients and knowing the patient’s
Autor:
C. L. Iñíguez, G. Gonzalez Arribas, F. Maceiras-Pan, J. L. Guerra-Vazquez, V. Quevedo Vila, L. Fernández-Dominguez, C. García-Porrúa, J. A. Mosquera Martínez, J. A. Pinto Tasende
Publikováno v:
Annals of the Rheumatic Diseases. 81:1607.3-1608
BackgroundPatients with psoriatic arthritis (PsA) show an impact on the physical and psychological aspect of the disease and it can be measured with the PsA Impact of Disease (PsAID) questionnaire, and it is expected that the impact of the disease im
Autor:
J. T. Sánchez-Costa, I. Hernández, E. Fernández-Fernández, M. T. Silva, J. A. Valero Jaimes, I. González Fernández, J. Sanchez-Martin, J. Lluch Pons, E. Galíndez-Agirregoikoa, J. Mendizabal, P. Lois, J. Loricera, A. Muñoz Jimenez., C. Valero, P. Moya, C. Larena, V. A. Navarro Angeles, J. Calvet, I. Casafont-Solé, F. Ortiz-Sanjuán, S. Labrada, J. Calvo, C. L. Iñíguez, V. Hernández Hernández, C. Campos Fernández, M. Alcalde Villar, A. J. Mas, E. De Miguel, J. Narváez, M. A. González-Gay, N. P. Garrido Puñal, P. Estrada, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:686.1-686
BackgroundGlucocorticoids (GC) are the mainstay therapy in Giant Cell Arteritis (GCA), initially at high doses (40-60 mg/day) followed by gradual glucocorticoid tapering. This treatment, especially in older patients, is associated with numerous adver
Autor:
J.L. Andreu Sánchez, A. García-Valle, S. Castañeda, C. L. Iñíguez, Rafael Melero, L. Sanchez-Bilbao, J. R. De Dios, Clara Moriano, I. Villa-Blanco, J. Sanchez, M. A. González-Gay, C. Fernández, Javier Loricera, C. Hidalgo, S. Manrique Arija, Monica Calderón-Goercke, Vicente Aldasoro, Eva Galíndez-Agirregoikoa, Eztizen Labrador-Sánchez, Roman Blanco, Eva Perez-Pampin, O. Maíz
Publikováno v:
Annals of the Rheumatic Diseases. 80:35-36
Background:Visual involvement is one of the most feared complication of Giant Cell Arteritis (GCA).Tocilizumab (TCZ) has shown efficacy and safety in large-vessel vasculitis (LVV) including GCA (1-4).Objectives:To assess the efficacy of TCZ to: a) pr
Autor:
C. García-Porrúa, J. A. Mosquera Martínez, J. Lorenzo-Alvarez, C. L. Iñíguez, V. Quevedo Vila, L. Fernández-Dominguez, J. L. Guerra-Vazquez, J. A. Pinto Tasende, F. Maceiras-Pan, M. Caeiro-Aguado
Publikováno v:
Annals of the Rheumatic Diseases. 80:1326.1-1326
Background:Evidence suggests that inflammation plays a causal role in the development of Metabolic Syndrome (MetS) and elevated peripheral levels of proinflammatory mediators, such as C-reactive protein (CRP) confering cardiovascular and metabolic ri